You are currently viewing LM stenting or surgery? Insights from Syntax Trial

LM stenting or surgery? Insights from Syntax Trial

LM stenting or surgery? Insights from Syntax Trial

European Bifurcation Club 2008 – EBC 2008 – Prague, Czech Republic

LM stenting or surgery ?

LM stenting or surgery? Insights from Syntax Trial

Author: Patrick W. Serruys MD, PhD, 

 

BACKGROUND

At the time of the trial design (in 2003-2004), a retrospective website survey of 104 medical centers over a period of 3 months showed that 12,072 patients (1/3 LM, 2/3 3VD) were revascularized by surgery (2/3) or by PCI (1/3).

The SYNTAX randomized trial is an attempt to provide an evidence-base to determine whether this approach, which is already currently practiced, is valid.

CONCLUSION

  • In the randomized SYNTAX cohort, there were comparable overall safety outcomes (Death, CVA, MI,) in CABG and PCI patients at 12 months (7.7 vs. 7.6 %).
  • There was a significantly higher rate of revascularization in the PCI group (13.7 vs. 5.9 %), and a significantly higher rate of CVA in the CABG group (2.2 vs. 0.6 %).
  • Overall MACCE in the PCI group was higher (17.8 vs.12.1 %) due to an excess of redo revascularization compared with CABG.
  • Per protocol rates of symptomatic graft occlusion and stent thrombosis were similar.
  • The SYNTAX score will help stratify patients for the appropriate revascularization option.

 

Download here

Leave a Reply